Lipoproteinasso- ciated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial. Circulation. 2006;113:1745 52. 259. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation. 2006;113:1071 8. 260. Mock MB, Ringqvist I, Fisher LD, et al. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circu- lation. 1982;66:562 8. 261. Vitarelli A, Tiukinhoy S, Di Luzio S, et al. The role of echocardiog- raphy in the diagnosis and management of heart failure. Heart Fail Rev. 2003;8:181 9. 262. Levy D, Garrison RJ, Savage DD, et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Fra- mingham Heart Study. Ann Intern Med. 1989;110:101 7. 263. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Fra- mingham Heart Study. N Engl J Med. 1990;322:1561 6. 264. Nagao T, Chikamori T, Hida S, et al. Quantitative gated singlephoton emission computed tomography with (99m)Tc sestamibi predicts major cardiac events in elderly patients with known or suspected coronary artery disease: the QGS-Prognostic Value in the Elderly (Q-PROVE) Study. Circ J. 2007;71:1029 34. 265. Leischik R, Dworrak B, Littwitz H, et al. Prognostic significance of exercise stress echocardiography in 3329 outpatients (5-year longi- tudinal study). Int J Cardiol. 2007;119:297 305. 266. Johansen A, Hoilund-Carlsen PF, Vach W, et al. Prognostic value of myocardial perfusion imaging in patients with known or suspected stable angina pectoris: evaluation in a setting in which myocardial perfusion imaging did not influence the choice of treatment. Clin Physiol Funct Imaging. 2006;26:288 95. 267. 